Cambrian Biopharma announced it raised $23 Million in an amended filing from an offering of $37.6 Million

Company

Location

About

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve overall quality of life as we age. To date, Cambrian has 14 novel therapeutics in development across its majority-held pipeline companies.